Cite
Breast Cancer Plasticity after Chemotherapy Highlights the Need for Re-Evaluation of Subtyping in Residual Cancer and Metastatic Tissues.
MLA
Padzińska-Pruszyńska, Irena Barbara, et al. “Breast Cancer Plasticity after Chemotherapy Highlights the Need for Re-Evaluation of Subtyping in Residual Cancer and Metastatic Tissues.” International Journal of Molecular Sciences, vol. 25, no. 11, June 2024, p. 6054. EBSCOhost, https://doi.org/10.3390/ijms25116054.
APA
Padzińska-Pruszyńska, I. B., Akbar, M. W., Isbilen, M., Górka, E., Kucukkaraduman, B., Canlı, S. D., Dedeoğlu, E., Azizolli, S., Cela, I., Akcay, A. G., Hakanoglu, H., Bodnar, L., Cierniak, S., Kozielec, Z., Pruszyński, J. J., Bittel, M., Gure, A. O., Król, M., & Taciak, B. (2024). Breast Cancer Plasticity after Chemotherapy Highlights the Need for Re-Evaluation of Subtyping in Residual Cancer and Metastatic Tissues. International Journal of Molecular Sciences, 25(11), 6054. https://doi.org/10.3390/ijms25116054
Chicago
Padzińska-Pruszyńska, Irena Barbara, Muhammad Waqas Akbar, Murat Isbilen, Emilia Górka, Baris Kucukkaraduman, Seçil Demirkol Canlı, Ege Dedeoğlu, et al. 2024. “Breast Cancer Plasticity after Chemotherapy Highlights the Need for Re-Evaluation of Subtyping in Residual Cancer and Metastatic Tissues.” International Journal of Molecular Sciences 25 (11): 6054. doi:10.3390/ijms25116054.